APTO - Aptose Biosciences Inc.
1.71
-1.440 -84.211%
Share volume: 670,384
Last Updated: 04-01-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$3.15
-1.44
-0.46%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-09-2024 | 03-28-2025 | 05-08-2025 | |
| Assets | ||||||
| Total Assets | 12.796 M | 10.949 M | 10.929 M | 10.127 M | 7.467 M | |
| Current Assets | 11.821 M | 10.159 M | 10.235 M | 9.530 M | 6.969 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 674.000 K | 593.000 K | 1.361 M | 570.000 K | 274.000 K | |
| Short Term Investments | 1.982 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.346 M | 8.330 M | 7.962 M | 6.152 M | 4.743 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 125.000 K | 34.000 K | 30.000 K | 26.000 K | 23.000 K | |
| Other Assets | 850.000 K | 756.000 K | 664.000 K | 571.000 K | 475.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 12.796 M | 10.949 M | 10.929 M | 10.127 M | 7.467 M | |
| Total liabilities | 12.659 M | 13.125 M | 20.063 M | 14.670 M | 14.860 M | |
| Total current liabilities | 12.139 M | 12.711 M | 9.758 M | 4.459 M | 6.318 M | |
| Accounts Payable | 2.421 M | 7.111 M | 1.830 M | 1.258 M | 2.390 M | |
| Other liabilities | 520.000 K | 414.000 K | 0.000 | 10.018 M | 8.462 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 10.000 M | 0.000 | 0.000 | |
| Other liabilities | 520.000 K | 414.000 K | 0.000 | 10.018 M | 8.462 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 137.000 K | -2.176 M | -9.134 M | -4.543 M | -7.393 M | |
| Common stock | 529.631 M | 534.569 M | 534.564 M | 540.740 M | 543.433 M | |
| Retained earnings | -525.177 M | -532.429 M | -539.382 M | -540.967 M | -546.510 M |